FDAmanufacturing / CMC66% confidence
Quality Information for Applicants | Chemistry, Manufacturing, and Controls (NDAs, ANDAs, BLAs, and IND applications)
Source: FDA
Why This Matters
Why this matters: provides agency context on manufacturing / CMC that may shape timing or evidence expectations for Janssen; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Quality Information for Applicants | Chemistry, Manufacturing, and Controls (NDAs, ANDAs, BLAs, and IND applications)
Supporting Context
- Therapeutic area
- Oncology · Bispecific T-cell Engager
- Sub-indication
- General
Related signal: FDA Accepts Supplement Application for TECVAYLI (BLA761291)